HMS TransMed Program

HMS TransMed: Identifying Unmet Medical Needs and Translational Solutions


In this course, students will investigate how unmet medical needs are identified, follow the discovery process that uncovers the causes of disease, and examine the practice of effective disease detection, diagnosis, and treatment. The course will feature assessments of unmet medical needs, case studies of successes and failures in translation, seminars from translational experts, and workshops that engage students in substantive and intensive discussions on current topics.  An optional component of the course will have students travel to Durban, South Africa, the center of the HIV epidemic to understand unmet needs in a resource-poor setting and devise potential solutions.

The deep understanding of translational medicine imparted by the HMS TransMed course will endow students with the requisite lens through which to identify the unmet medical needs of patients and engage in the creation of novel interventions.


To engage future biomedical research leaders in the practice of translational medicine.


This program is expected to serve MD, MD/PhD, and PhD students from Harvard Medical School, Harvard University, and MIT, and MD students and fellows from other US and international institutions. Enrollment will be limited to 30 students.


Two weeks of intensive class work at Harvard Medical School

One week of field work in Durban, South Africa, Hosted by the HIV Pathogenesis Programme

Institute for Medical Engineering & Science

HMS TransMed Faculty of Interest

Faculty Director  
Jagesh Shah, PhD HMS/BWH
Global Component Co-Director
Filippos Porichis, PhD The Ragon Institute
Course Faculty  
Catherine Dubreuil, PhD HMS
Participating Faculty (for complete list see Faculty tab) 
Tim Mitchison, PhD, HMS/HiTS
Daniel DeAngelo, MD, DFCI
Paul Ridker, MD, BWH
Mark Trusheim, PhD, MIT/Sloan
Peter Sorger, PhD
Jerry Avorn, MD HMS/HiTS, BWH
Oxana Beskrovnaya, PhD, Genzyme/Sanofi
Ann Kwong, PhD, InnovaTID
Edward Garmey, MD, Cerulean Pharma, Inc.
Kimberley Stickland, PhD, DABT, Epizyme
Mark Goldberg, MD, Synageva
Sanyal Subhabrata, PhD Biogen IDEC